Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA CAR-NK Cell Injection for the Treatment of Refractory Pediatric Rheumatic Diseases

Clinical trial NCT07490041 · RECRUITING

Trial details

NCT number: NCT07490041
Sponsor: The Children's Hospital of Zhejiang University School of Medicine
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Rheumatic Diseases Pediatric Rheumatological Condition (i.e., Arthritis, SLE, Kawasaki's Disaese)Systemic Lupus Erythematosus (SLE)Connective Tissue Disease-associated Interstitial Lung Disease

Start date: 2026-03-19
Primary completion: 2026-12-19
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.